Biophysics×CRISPR

The Frontier Brief for this collision is still being written. The evidence below already reflects the current model run.

Pre-company space. No named players have staked this collision yet — an emerging pairing where the field, not a firm, is the story so far.

47 researchers publish on both sides of this collision without the fields themselves having met. Every name below is counted from papers in the corpus — not inferred.

• Eugene V. KooninMontana State University
  1/11
• Hans CleversLustgarten Foundation
  1/6
• Eva NogalesInnovative Genomics Institute
  3/2
• Konstantin SeverinovUniversity of Leeds
  1/3
• Jiawei WangChinese Academy of Agricultural Sciences
  3/1
• Osamu NurekiJapan Science and Technology Agency
  3/1
• Jillian F. BanfieldUniversity of California, Davis
  1/3
• Ning GaoState Key Laboratory of Plant Genomics
  2/1
• Ilia VoskoboinikUniversity College London
  1/2
• Róbert LangerPhiladelphia University
  1/2

• Howard Hughes Medical InstituteUS
  109/185
• Harvard UniversityUS
  105/191
• Massachusetts Institute of TechnologyUS
  41/136
• Stanford UniversityUS
  48/114
• University of California, San FranciscoUS
  54/98
• Broad InstituteUS
  27/160

• Thermo‐triggered Release of CRISPR‐Cas9 System by Lipid‐Encapsulated Gold Nanoparticles for Tumor Therapy2017 · 408 citations · DOI ↗
  2
• In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy2018 · 1,066 citations · DOI ↗
  3
• Sensitive red protein calcium indicators for imaging neural activity2016 · 1,149 citations · DOI ↗
  2
• Semiconducting Polymer Nanobioconjugates for Targeted Photothermal Activation of Neurons2016 · 461 citations · DOI ↗
  2

Counted from the corpus. Institution counts use best-effort affiliation (every author on a paper is paired with every institution on it), so read them as presence, not headcount.